Two pharmaceutical companies have rejected calls to lower prices for two lifesaving multiple sclerosis medications, potentially costing patients up to $33,000.

Click PLAY to hear the full conversation.

Dr Julia Morahan of MS Australia told 6PR Mornings host Chrissy Morrissy that the essential drugs must remain on the Pharmaceutical Benefits Scheme to preserve patient quality of life.

“It is able to keep people very stable in their disease and [give a] much better quality of life, able to be part of the workforce, able to live their life as well as they possibly can,” she said.

Hear more highlights below and download the 6PR app on iOS or Android to ensure you don’t miss a thing!